Department of Surgery, Meander Medical Center, P.O. box 1502, 3800 BM, Amersfoort, The Netherlands.
Department of Surgery, University of Twente, Enschede, The Netherlands.
Surg Endosc. 2019 Jul;33(7):2152-2161. doi: 10.1007/s00464-018-6494-4. Epub 2018 Oct 22.
Published data regarding robot-assisted hiatal hernia repair are mainly limited to small cohorts. This study aimed to provide information on the morbidity and mortality of robot-assisted complex hiatal hernia repair and redo anti-reflux surgery in a high-volume center.
All patients that underwent robot-assisted hiatal hernia repair, redo hiatal hernia repair, and anti-reflux surgery between 2011 and 2017 at the Meander Medical Centre, Amersfoort, the Netherlands were evaluated. Primary endpoints were 30-day morbidity and mortality. Major complications were defined as Clavien-Dindo ≥ IIIb.
Primary surgery 211 primary surgeries were performed by two surgeons. The median age was 67 (IQR 58-73) years. 84.4% of patients had a type III or IV hernia (10.9% Type I; 1.4% Type II; 45.5% Type III; 38.9% Type IV, 1.4% no herniation). In 3.3% of procedures, conversion was required. 17.1% of patients experienced complications. The incidence of major complications was 5.2%. Ten patients (4.7%) were readmitted within 30 days. Symptomatic early recurrence occurred in two patients (0.9%). The 30-day mortality was 0.9%. Redo surgery 151 redo procedures were performed by two surgeons. The median age was 60 (IQR 51-68) years. In 2.0%, the procedure was converted. The overall incidence of complications was 10.6%, while the incidence of major complications was 2.6%. Three patients (2.0%) were readmitted within 30 days. One patient (0.7%) experienced symptomatic early recurrence. No patients died in the 30-day postoperative period.
This study provides valuable information on robot-assisted laparoscopic repair of primary or recurrent hiatal hernia and anti-reflux surgery for both patient and surgeon. Serious morbidity of 5.2% in primary surgery and 2.6% in redo surgery, in this large series with a high surgeon caseload, has to be outweighed by the gain in quality of life or relief of serious medical implications of hiatal hernia when counseling for surgical intervention.
已发表的关于机器人辅助食管裂孔疝修复的数据主要局限于小队列。本研究旨在提供在高容量中心机器人辅助复杂食管裂孔疝修复和再手术抗反流手术的发病率和死亡率信息。
评估了 2011 年至 2017 年间荷兰阿默斯福特 Meander 医疗中心进行的机器人辅助食管裂孔疝修复、再食管裂孔疝修复和抗反流手术的所有患者。主要终点为 30 天发病率和死亡率。主要并发症定义为 Clavien-Dindo ≥ Ⅲb。
主要手术 211 例手术由两名外科医生进行。中位年龄为 67(IQR 58-73)岁。84.4%的患者存在 III 型或 IV 型疝(10.9%I 型;1.4%II 型;45.5%III 型;38.9%IV 型,1.4%无疝)。有 3.3%的手术需要转换。17.1%的患者发生并发症。主要并发症发生率为 5.2%。10 例(4.7%)患者在 30 天内再次入院。2 例(0.9%)患者出现症状性早期复发。30 天死亡率为 0.9%。再手术 151 例再手术由两名外科医生进行。中位年龄为 60(IQR 51-68)岁。有 2.0%的手术需要转换。总并发症发生率为 10.6%,而主要并发症发生率为 2.6%。3 例(2.0%)患者在 30 天内再次入院。1 例(0.7%)患者出现症状性早期复发。在 30 天的术后期间,没有患者死亡。
本研究为机器人辅助腹腔镜治疗原发性或复发性食管裂孔疝和抗反流手术提供了有价值的信息,对患者和外科医生都有帮助。在本系列中,主要手术的严重发病率为 5.2%,再手术为 2.6%,在高外科手术量的情况下,必须权衡生活质量的提高或食管裂孔疝严重医疗后果的缓解,以决定是否进行手术干预。